Upgrading your best chances: postdiagnosis smoking cessation boosts life expectancy of patients with cancer – a systematic review and meta-analysis
- 6 January 2025
- journal article
- review article
- Published by BMJ in Tobacco Control
- Vol. 35 (2) , 240-249
Abstract
Background: Tobacco use is linked to increased cancer risk, and people who smoke represent a large proportion of newly diagnosed patients with cancer. The fact that smoking cessation at the time of diagnosis can improve the patient’s life expectancy is still not broadly understood. We conducted a systematic review and meta-analysis to quantify the survival benefits obtainable by quitting smoking on diagnosis. We included articles found in MEDLINE and EMBASE until 2 January 2024. We conducted a random effects meta-analysis, studying correlates of between-studies heterogeneity and exploring the presence of publication bias. There were 36 eligible studies published in 1980–2023, totalling over 17 000 actively smoking patients with cancer. The most studied cancer sites were the lung (n=17) and head and neck (n=14). The median proportion of patients who quit on diagnosis was 42.5%. Postdiagnosis cessation was associated with longer overall survival (summary HR (sHR) 0.71, 95% CI 0.65 to 0.78), progression-free survival (sHR 0.64, 95% CI 0.41 to 0.98), disease-free/recurrence-free survival (sHR 0.59, 95% CI 0.43 to 0.81) and improved local/locoregional control (sHR 0.69, 95% CI 0.50 to 0.94). Heterogeneity was generally large; for overall survival, study results were stronger when properly adjusted but did not vary across cancer sites. There was evidence for publication bias, but the results were only marginally altered on imputation of potentially missing studies. Postdiagnosis smoking cessation is effective in improving the chances of survival for patients with cancer. Cessation support programmes should be integrated into the routine management of patients with cancer as they may favourably affect survival.Keywords
Funding Information
- Ministero della Salute (Ricerca Corrente and 5 x 1000 funds - no grant num)
This publication has 76 references indexed in Scilit:
- Cigarette smoking cessation, duration of smoking abstinence, and head and neck squamous cell carcinoma prognosisCancer, 2023
- Impact of smoking cessation on clinical outcomes in patients with head and neck squamous cell carcinoma receiving curative chemoradiotherapy: A prospective studyHead & Neck, 2019
- SIPA1L3 methylation modifies the benefit of smoking cessation on lung adenocarcinoma survival: an epigenomic–smoking interaction analysisMolecular Oncology, 2019
- The Impact of Compliance in Posttreatment Surveillance in Head and Neck Squamous Cell CarcinomaJAMA Otolaryngology–Head & Neck Surgery, 2015
- Sustained Care Intervention and Postdischarge Smoking Cessation Among Hospitalized AdultsJAMA, 2014
- Screening for local and regional cancer recurrence in patients curatively treated for laryngeal cancer: Definition of a high‐risk group and estimation of the lead timeHead & Neck, 2006
- Association between smoking during radiotherapy and prognosis in head and neck cancer: A follow‐up studyHead & Neck, 2002
- Extracting summary statistics to perform meta-analyses of the published literature for survival endpointsStatistics in Medicine, 1998
- Head and Neck Cancer Survival and Life-style ChangeJAMA Otolaryngology–Head & Neck Surgery, 1983
- Smoking Abstinence and Small Cell Lung Cancer SurvivalJAMA, 1980